Global /China /Healthcare /Medical Devices /301033

Medprin Regenerative Medical Technologies Co., Ltd.

301033

• SHE: 301033 • Delayed

55.06CNY -1.2%

8.14 USD

As of 14 June 2026, Medprin Regenerative Medical Technologies Co., Ltd. has a market cap of $548.46M USD, ranking #14515 globally and #4496 in China. It ranks #1292 in the Healthcare sector, and #261 in the Medical Devices industry.

Global Rank

14515

Country Rank

4496

Sector Rank

1292

Industry Rank

261

Key Stats

Market Cap

$548.46MUSD

3.72B CNY

Enterprise Value

$506.01MUSD

3.42B CNY

Revenue (TTM)

$55.12MUSD

373.49M CNY

EBITDA (TTM)

$22.31MUSD

151.0M CNY

Net Income (TTM)

$16.19MUSD

109.68M CNY

EBITDA Margin

40%

Profit Margin

29%

PE Ratio

34.0

PS Ratio

10.0

PB Ratio

4.5

EV/EBITDA

22.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Jianhua Wang open_in_new

Employees

337

Founded

2008

Website

medprin.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.2%	-2.7%	-14%	-18%	-24%	-18%	-0.6%	29%	-43%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301033 广州迈普再生医学科技股份有限公司 Class A ISIN: CNE100004NB8 Shares Out.: Shares Outstanding: 66.808M¹ TV: TradingView: SZSE: 301033 SA: Stock Analysis: SHE: 301033 YF: Yahoo Finance: 301033.SZ GF: Google Finance: SHE: 301033 BA: Barron's: 301033 MS: Morningstar: XSHE: 301033	55.06 CNY	TV: TradingView: SZSE: 301033 SA: Stock Analysis: SHE: 301033 YF: Yahoo Finance: 301033.SZ GF: Google Finance: SHE: 301033 BA: Barron's: 301033 MS: Morningstar: XSHE: 301033

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Medprin Regenerative Medical Technologies Co., Ltd.

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal, a dural sealant system; and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is based in Guangzhou, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 5K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.61B 92.23B CNY 2K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 923%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 907%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 819%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 730%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 31K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 29K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 29K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 23K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 22K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 18K%	22.2	Ireland

chevron_leftBack